Detalhe da pesquisa
1.
Macrophages in multiple myeloma: key roles and therapeutic strategies.
Cancer Metastasis Rev
; 40(1): 273-284, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33404860
2.
A niche-dependent myeloid transcriptome signature defines dormant myeloma cells.
Blood
; 134(1): 30-43, 2019 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31023703
3.
Fragmentation of tissue-resident macrophages during isolation confounds analysis of single-cell preparations from mouse hematopoietic tissues.
Cell Rep
; 37(8): 110058, 2021 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818538
4.
LCRF-0006, a small molecule mimetic of the N-cadherin antagonist peptide ADH-1, synergistically increases multiple myeloma response to bortezomib.
FASEB Bioadv
; 2(6): 339-353, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32617520
5.
GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice.
PLoS One
; 15(1): e0228408, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31995627
6.
Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo.
Cancers (Basel)
; 12(8)2020 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32756430
7.
Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo.
Neoplasia
; 21(8): 777-787, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31247457